Rationale: Vascular fibrosis and calcification contribute to diabetic arteriosclerosis, impairing Windkessel physiology necessary for distal tissue perfusion. Wnt family members, upregulated in arteries by the low-grade inflammation of "diabesity," stimulate type I collagen expression and osteogenic mineralization of mesenchymal progenitors via ␤-catenin. Conversely, parathyroid hormone (PTH) inhibits aortic calcification in low-density lipoprotein receptor (LDLR)-deficient mice fed high fat diabetogenic diets (HFD). Objective: We sought to determine the impact of vascular PTH receptor (PTH1R) activity on arteriosclerotic Wnt/␤-catenin signaling in vitro and in vivo. We generated SM-caPTH1R transgenic mice, a model in which the constitutively active PTH1R variant H223R (caPTH1R) is expressed only in the vasculature. Methods and Results: The caPTH1R inhibited Wnt/␤-catenin signaling, collagen production, and vascular smooth muscle cell proliferation and calcification in vitro. Transgenic SM-caPTH1R;LDLR ؉/؊ mice fed HFD develop diabesity, with no improvements in fasting serum glucose, cholesterol, weight, body composition, or bone mass versus LDLR ؉/؊ siblings. SM-caPTH1R downregulated aortic Col1A1, Runx2, and Nox1 expression without altering TNF, Msx2, Wnt7a/b, or Nox4. The SM-caPTH1R transgene decreased aortic ␤-catenin protein accumulation and signaling in diabetic LDLR ؉/؊ mice. Levels of aortic superoxide (a precursor of peroxide that activates pro-matrix metalloproteinase 9 and osteogenic signaling in vascular smooth muscle cells) were suppressed by the SM-caPTH1R transgene. Aortic calcification, collagen accumulation, and wall thickness were concomitantly reduced, enhancing vessel distensibility. Conclusions: Cell-autonomous vascular smooth muscle cell PTH1R activity inhibits arteriosclerotic Wnt/␤-catenin signaling and reduces vascular oxidative stress, thus limiting aortic type I collagen and calcium accrual in diabetic LDLR-deficient mice. (Circ Res. 2010;107:271-282.)
A therosclerosis and medial artery calcification are 2 contributors to arteriosclerosis: the vascular stiffening that impairs Windkessel physiology necessary for smooth distal tissue perfusion and efficient cardiac performance. 1 Arteriosclerotic changes in mural biochemical and geometric properties are responsible for functional ageing of conduit arteries. 1 In the musculoskeletal system, the lower extremities bear the brunt of disease burden arising from arteriosclerosis. 2, 3 Claudication, critical limb ischemia, and amputation are salient manifestations that reduce mobility and increase morbidity in our patients. 2, 3 In either the presence or absence of type 2 diabetes (T2DM), the presence and extent of vascular calcification portends lower extremity amputation risk. 3 Demer, Shanahan, and colleagues demonstrated the elaboration of osteochondrogenic regulatory programs in calcifying segments of patients with vascular disease, indi-cating that active biomineralization programs contribute to arterial calcium accrual. 4, 5 Rajamannan, Miller, Heistad, and colleagues 6 -8 have made similar observations in calcific aortic stenosis, a lethal sclerotic vasculopathy also increased by T2DM and advancing age. 9 A fundamental understanding of the procalcific and profibrotic mechanisms of diabetic arteriosclerosis is necessary to develop new strategies to address the burgeoning vascular disease burden afflicting our population. 4 In our preclinical studies of arterial calcification, we have implemented the low-density lipoprotein receptor (LDLR)deficient mouse model. 10 When LDLR Ϫ/Ϫ mice are fed high-fat Western diets (HFDs), male animals develop obesity, diabetes, hyperinsulinemia, hypertriglyceridemia, and hypercholesterolemia, with progressively severe arterial calcification. 11 Whereas medial calcification predominates at early disease stages, at later stages, atherosclerotic intimal calcification increasingly accounts for vascular calcium load. 11, 12 Without HFD-induced "diabesity," vascular disease phenotypes are markedly attenuated. However, in the presence of selective apolipoprotein (Apo)B100 expression, LDLRdeficient mice develop hemodynamically significant calcific aortic stenosis, even when aged on standard rodent chow diets. 13 In LDLR Ϫ/Ϫ ;ApoB(100/100) mice, cholesteroldependent initiation and reversal of age-associated aortic valve calcification is heralded by vascular changes in osteogenic transcription factors, including Msx2 (muscle segment homeobox protein homolog 2). 14 Similarly, at the very earliest stages of HFD-induced diabesity and dyslipidemia, osteogenic gene regulatory programs are upregulated in the aortas of LDLR-deficient mice. 15, 16 Within 2 weeks of HFD challenge, the osteogenic transcription factor Msx2 is ectopically induced in aortic valve fibrosa and aortic adventitia. 15, 16 Msx2 enhances cardiovascular calcification by activating paracrine Wnt (wingless-type integration site family member) signals that drive osteogenic 17 and myofibroblast 17, 18 differentiation programs in adjacent mesenchymal progenitors. 16 -18 Inflammatory cytokines, matrix metalloproteinases (MMPs), and reactive oxygen species (ROS) initiate and propagate these processes, activating mural ␤-catenin signals. 11, 19 ␤-Catenin is a transcriptional coadaptor indispensable for osteogenic tissue mineralization 20 and participates in osteochondrogenic differentiation of mural mesenchymal progenitors. 21 In the vasculature, ␤-catenin activity is not only entrained to tumor necrosis factor (TNF) and Msx2-Wnt activity 11 ; N-cadherin-and MMP-regulated cell-cell interactions reciprocally control ␤-catenin signals that drive vascular smooth muscle cell (VSMC) proliferation and neointima formation. 19, 22 Moreover, ROS activate pro-MMP9, 23 which, in turn, cleaves cell surface N-cadherin and liberates the cadherin-sequestered pool of ␤-catenin to promote signaling. 19 Thus, data from multiple laboratories have converged on ␤-catenin activation as a key component of arteriosclerotic physiology. 8, 16, 19, 21, 24 Previously, we demonstrated that dosing with the bioactive human parathyroid hormone (PTH) fragment PTH(1-34) reduced vascular mineralization, downregulated aortic Msx2-Wnt expression, and inhibited Wnt-activated ␤-catenin signaling. 16, 25 However, in vivo PTH(1-34) administration may exert both direct and indirect actions on vascular physiology. Whereas the PTH/PTHrP receptor (PTH1R) is expressed and biologically active in VSMCs, 26, 27 PTH1R activation by PTH in kidney, bone, and hematopoietic niche may also influence arteriosclerotic processes. 28 Thus, to better understand the role of VSMC PTH1R signaling in arteriosclerosis, we generated SM-caPTH1R transgenic mice. In this model, the constitutively active Jansen PTH1R (caPTH1R) variant PTH1R(H223R) 29 is expressed in VSMCs using the 0.5-kb SM22 (transgelin) promoter. 11, 30 We find that VSMCautonomous PTH1R signaling decreases aortic activation of procalcific and profibrotic ␤-catenin signals diminishes vascular oxidative stress and reduces aortic collagen and calcium accrual the LDLR-deficient mouse model of diabetic vascular disease.
Methods
An expanded Methods section detailing the materials, methods, and statistics implemented in this study is available in the Online Data Supplement at http://circres.ahajournals.org.
Procedures for generating and evaluating mice transgenic for SM-caPTH1R were approved by the Washington University Animal Studies Committee. LDLR Ϫ/Ϫ mice (stock no. 002207) and TOPGAL mice (stock no. 004623) were obtained from The Jackson Laboratories. Diet-induced diabetes was initiated in male sibling cohorts at 5 to 8 weeks of age by ad libitum feeding with the "Western" HFD (Harlan TD.88137; 42% of calories from fat). Following 3 to 4 months of dietary challenge, body composition, serum biochemistries, aortic pathology, and aortic gene expression were analyzed. 11 Data are presented as the meansϮSE of independent replicates (nϭ3 to 22, dependent on the assay). 
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Results
Wnt/␤-Catenin Signaling Elicits Profibrotic and Procalcific Responses in C3H10T1/2 Multipotent Mural Mesenchymal Progenitors
In male LDLR Ϫ/Ϫ mice, diabetogenic HFD upregulates TNF-dependent aortic Msx2-Wnt signaling cascades that promote vascular calcium deposition. 11, 25 Wnt7a and Wnt7b are vascular Wnts 11, 16, 31, 32 that participate in Msx2 proosteogenic actions. 16, 33 Like Wnt3a, Wnt7a, and Wnt7b also stimulate canonical ␤-catenin signaling in C3H10T1/2 cells, as evident in TCF/LEF optimal promoter (TOP), luciferase reporter (LUC) activation ( Figure 1A ). To better understand the contributions of the Wnt7 family to vascular fibrosis and calcification, we examined Wnt7 effects on C3H10T1/2, a multipotent mural mesenchymal progenitor 34 that elaborates both osteogenic 17 and vascular smooth muscle 18, 34 phenotypes. We generated SFG-Wnt7a and SFG-Wnt7b (vesicular stomatitis virus G protein pseudotyped retroviral vectors [SFG 35 ] for Wnt7 expression 17 ) and assessed the impact of SFG-Wnt7 transduction on collagen gene expression, collagen protein production, and mineral deposition. As compared to cultures transduced with SFG-LacZ (␤-galactosidase; control), cultures transduced with SFG-Wnt7a or SFG-Wnt7b exhibited increased expression of type I collagen (Col1A1 and Col1A2; Figure 1B ) and increased collagen protein content ( Figure 1C ). Col2A1, Col6A1, and Col10A1 were concomitantly suppressed, indicating selective activation of a proosteogenic 36 collagen gene regulatory program ( Figure  1B ). Bone alkaline phosphatase enzyme activity ( Figure 1D ) and mRNA (data not shown) were also induced by SFG-Wnt7. Moreover, when cultured under conditions permissive for matrix mineralization, SFG-Wnt7 significantly increased calcium deposition in cultured cells as compared to SFG-LacZ control ( Figure 1E ). Thus, signals provided by Wnt7a and Wnt7b elicit profibrotic and procalcific responses characteristic of osteogenic differentiation in C3H10T1/2 mural mesenchymal progenitor cells. 34 
Canonical ␤-Catenin Transcriptional Responses Elicited by Wnt Signaling Are Inhibited by PTH1R Activation
PTH(1-34) (also known as teriparatide) is a clinically useful agonist of the PTH1R that simultaneously stimulates bone formation and inhibits vascular calcification in diabetic 25 and uremic 37 rodent models. Because Wnt/␤-catenin cascades 24 participate in diabetic arteriosclerosis, 11, 16 we examined the impact of PTH/PTH1R activation on Wnt/␤-catenin-regulated transcription, including type I collagen expression. For these experiments, we implemented primary mouse aorta VSMCs and A7r5 cells, a SM22␣-expressing rat aorta VSMC line that faithfully recapitulates key features of VSMCspecific gene transcription. 38 PTH(1-34) inhibits TOPLUC activation by either Wnt3a (Figure 2A ) or by Wnt7a/b (data not shown), indicating that Wnt7a, Wnt7b, and Wnt3a elaborate similar PTH-sensitive canonical signals in VSMCs. Likewise, PTH(1-34) significantly reduces Wnt7a-and Wnt7b-stimulated Col1A1 and Col1A2 expression in primary aortic VSMCs ( Figure 2B ). Moreover, using the 0.5-kb SM22-promoter 30 to drive expression, coexpression of PTH1R(H223R) (a constitutively active form of the PTH1R [caPTH1R] that does not require ligand for activation 29 ) inhibited Wnt7-activated TOPLUC transcription in A7r5 VSMCs ( Figure 2C ) and primary aortic VSMC cultures (data not shown). Suppression of transcription by caPTH1R was promoter-specific, because SM-caPTH1R stimulated cAMP responsive pCRE-LUC, as expected in transient cotransfec- tion assays ( Figure 2D ). The caPTH1R also inhibited basal ( Figure 2E ), Wnt3a (data not shown), and Wnt7a-stimulated ( Figure 2E ) Col1A1 promoter activity, as reflected by 3.6ColA1-LUC (3.6-kb Col1A1 promoter) activity in aortic VSMCs. Similar responses were observed with the 2.3-kb Col1A1 promoter fragment (data not shown). 1 Finally, retroviral transduction of primary aortic VSMC with SFG-caPTH1R reduced basal collagen protein accumulation versus cultures transduced with SFG-LacZ ( Figure 2F ). Thus, PTH/PTH1R activation inhibits Wnt/␤-catenin signaling, type I collagen expression, and collagen protein accumulation in aortic VSMC cultures. 25 ). However, PTH(1-34) dosing also exerts global effects (eg, changes in skeletal hematopoietic niche size, 28 circulating OPN, 25, 39 and ROS-generated oxylipid signals 23 ; Online Figure II ) that control vascular disease processes. 4, 39 We sought to assess whether VSMC-autonomous PTH1R signaling could convey a subset of PTH(1-34) responses; therefore, we generated mice transgenic for a constitutively active PTH1R (caPTH1R), 29 using the 0.5-kb SM22 promoter 30 as a delivery module (SM-caPTH1R; Figure 3A ). The SM-caPTH1R expression vector we validated by A7r5 transient transfection ( Figure 2D ) was digested with AclI and NdeI to liberate the SM-caPTH1R-␤globin untranslated region fragment ( Figure 3A) , and transgenic mice were generated (see Methods). Subsequently, we bred the SM-caPTH1R transgene onto the heterozygous LDLR ϩ/Ϫ background, a LDLR-deficient background of intermediate vascular disease severity. 40 As in LDLR Ϫ/Ϫ mice, HFD upregulates aortic expression of Msx2 in LDLR ϩ/Ϫ mice (Online Figure III) ; however, 3 to 4 months of HFD feeding in LDLR ϩ/Ϫ mice was required to achieve significant diabetes, and cholesterol levels were much lower in LDLR ϩ/Ϫ versus LDLR Ϫ/Ϫ mice (Online Figure IV) . Analysis of aortic extracts from SM-caPTH1R;LDLR ϩ/Ϫ transgenic mice demonstrated a 2.5-fold increase in PTH1R protein levels versus nontransgenic siblings ( Figure 3B ; PϽ0.01). We then challenged male SM-caPTH1R;LDLR ϩ/Ϫ and LDLR ϩ/Ϫ sibling cohorts with 4 months of HFD, assessing the impact on body composition and metabolic profiles. As shown in Figure 3C , SM-caPTH1R;LDLR ϩ/Ϫ mice exhibited no significant differences in bone mineral content, lean body mass, or fat mass, as assessed by dual-electron x-ray absorptiometry. 25 Serum glucose and cholesterol levels were not reduced by the transgene and were, in fact, slightly higher in SM-caPTH1R animals ( Figure 3D ). No significant differences were observed in serum triglycerides and free fatty acids. Similarly, no significant differences were observed in fasting serum calcium, PTH, 8-F-isoprostane, or markers of bone turnover (Online Table I ). Because SM-caPTH1R inhibited Wnt activation of TCF/ LEF-LUC in A7r5 VSMCs, we hypothesized that SM-caPTH1R may inhibit ␤-catenin activation signaling in VSMCs of the aortic tunica media. 11, 16 To test this notion, we generated SM-caPTH1R;TOPGAL ϩ ;LDLR ϩ/Ϫ mice and scored the aortic extent of LacZ (␤-galactosidase) staining as an index of mural ␤-catenin activation registered by the TOPGAL reporter. 41 As shown in Figure 4A and 4B, SM-caPTH1R;TOPGAL ϩ ;LDLR ϩ/Ϫ mice exhibited significantly fewer aortic LacZ ϩ cells versus nontransgenic TOPGAL ϩ ; LDLR ϩ/Ϫ siblings fed HFD. Furthermore, by Western blot analysis, 16 aortic ␤-catenin protein levels were significantly reduced in SM-caPTH1R transgenics ( Figure 4C ), confirming the inhibition of ␤-catenin signaling. We next examined Dkk1 regulation. Dkk1 is highly expressed in aorta 42 and is a direct endogenous target of ␤-catenin signaling 43 that participates in a negative feedback loop to curtail excessive Wnt receptor activation. 24 In vitro, Wnt3a upregulates Dkk1 promoter (LUC reporter) activity in aortic VSMCs, and caPTH1R inhibits Wnt3a-dependent induction ( Figure 4D ). In vivo, the SM-caPTH1R transgene also significantly reduced aortic Dkk1 mRNA accumulation ( Figure 4E ) and circulating levels of Dkk1 protein (data not shown). Thus, caPTH1R signaling downregulates aortic VSMC ␤-catenin signaling in vivo.
SM-caPTH1R Transgene Expression
SM-caPTH1R Transgene Reduces Diabetic Arteriosclerotic Gene Expression and Fibrosis Without Altering Expression of Vascular TNF, Msx2, BMP2, or Wnt7
Diabesity-induced TNF upregulates vascular BMP2 and Msx2-Wnt expression and activates Wnt/␤-catenin signals in vivo. 11, 16 Thus, reductions in vascular ␤-catenin signaling in response to the SM-caPTH1R transgene could be mediated via reductions in aortic TNF, Msx2, BMP2, or Wnt7. To test this, we extracted whole aorta RNA from SM-caPTH1R;LDLR ϩ/Ϫ transgenic and nontransgenic LDLR ϩ/Ϫ siblings fed HFD and evaluated gene expression by reverse transcription-quantitative PCR. Unlike results obtained with PTH(1-34) 16, 25 or infliximab 11 administration, aortic expression of TNF, Msx2, BMP2, and Wnt7a were not significantly altered by the SM-caPTH1R transgene ( Figure 5A ). The expression of other vascular Wnt ligands such as Wnt3a and Wnt7b were also unaltered (data not shown). By contrast, as compared with nontransgenic sibling cohorts, SM-caPTH1R mice on HFD exhibited reduced aortic OPN and COL1A1 gene expression ( Figure 5A ). MMP9, a target of OPNdependent ROS signaling in diabetic arteriosclerosis, 23, 44 was also diminished by caPTH1R ( Figure 5A ), whereas MMP2 and Nox4, the most abundant NADPH oxidase of VSMCs, were unaffected. However, Nox1, a NADPH oxidase that selectively conveys VSMC activation by advanced glycosylation products in diabetes, 45 was decreased. Moreover, expression of Runx2, an osteochondrogenic transcription factor targeted by ROS signaling in VSMCs, 46 was significantly diminished (confirmed by Western blot; data not shown). The reductions in aortic ␤-catenin signaling and Runx2 expression without changes in upstream TNF, Msx2, BMP2, or Wnt7 arteriosclerotic stimuli suggested that mural PTH1R activa-tion might reduce aortic collagen accumulation and calcium accrual in vivo as in vitro. To test this notion, SM-caPTH1R;LDLR ϩ/Ϫ mice and nontransgenic LDLR ϩ/Ϫ siblings were placed on diabetogenic HFD for 12 weeks, and aortas were extracted for calcium and collagen content. As shown in Figure 5B , no difference in body weight was observed between cohorts. However, aortic calcium content (Pϭ0.03) and collagen content (Pϭ0.04) were significantly reduced in SM-caPTH1R;LDLR ϩ/Ϫ transgenic mice versus nontransgenic siblings. Histological staining for calcium deposition with Alizarin red demonstrated that transgeneregulated calcium deposition occurred primarily within the aortic tunica media ( Figure 5C ). Furthermore, cultures of transgenic aortic VSMCs exhibited reduced mineralization in vitro as compared with nontransgenic LDLR ϩ/Ϫ "WT" controls ( Figure 5D ). Twenty-four-hour fasting urinary calcium/ creatinine ratios were not altered, indicating that the transgene did not enhance urinary calcium clearance (Online Figure V) . Serum P1NP, a marker of type I collagen biosynthesis, 36 was reduced in SM-caPTH1R;LDLR ϩ/Ϫ mice on HFD ( Figure 5E ). Histological staining of collagen with Picrosirius red confirmed reductions in aortic fibrosis by the SM-caPTH1R transgene ( Figure 5F ). Diabetic SM-caPTH1R;LDLR Ϫ/Ϫ mice also exhibited reduced aortic collagen content as compared to nontransgenic LDLR Ϫ/Ϫ siblings (Online Figure VI) . Histomorphometric analysis revealed reduced aortic wall thickness in SM-caPTH1R;LDLR ϩ/Ϫ mice ( Figure 5G ), reflecting transgeneinduced reductions in VSMC proliferation (Online Figure  VII) . Consistent with reductions in collagen, calcification, and wall thickness, aortas from SM-caPTH1R transgenic mice exhibited increased distensibility by ex vivo plethysmography ( Figure 5H ). Thus, VSMC PTH1R activity directly inhibits procalcific and profibrotic ␤-catenin signaling in aortas of diabetic LDLR-deficient mice, downregulating Nox1 and Runx2 without altering TNF, Msx2, BMP2, or Wnt7 expression. VSMC-autonomous PTH1R signaling recapitulates many, but not all, effects of systemic PTH(1-34) on diabetic arteriosclerosis. 25
SM-caPTH1R Transgene Reduces Aortic Superoxide Accumulation
Oxidative stress plays a key role in diabetic arteriosclerosis, 6, 44, 45 and systemic PTH(1-34) administration globally reduced oxidative stress reflected in serum 8-F-isoprostane in LDLR Ϫ/Ϫ mice (Online Figure II) . 23 SM-caPTH1R transgene did not globally reduce oxidative stress (Table I) ; however, the SM-caPTH1R transgene did reduce aortic Nox1 (a key VSMC source of superoxide 45 ) and aortic OPN (a stimulus for Nox activation 23, 44 ). Therefore, we assessed the impact of SM-caPTH1R transgene on aortic superoxide, a direct measure of local tissue oxidative stress. As shown in Figure 6A , the SM-PTH1R transgene significantly reduced aortic superoxide levels in LDLR ϩ/Ϫ mice as measured by lucigenin assay 45 ; similar inhibition was observed in LDLR Ϫ/Ϫ mice (Online Figure VIII) . Moreover, VSMC pro-MMP9 activation (a target and index of Nox/ROS signaling 19 ) was also downregulated by the caPTH1R transgene ( Figure  6B ). Dihydroethidium staining 23 confirmed reductions in superoxide in VSMC expressing caPTH1R (data not shown). Thus, VSMC PTH1R signaling reduces aortic VSMC superoxide levels in LDLR-deficient mice fed diabetogenic diets.
Discussion
Once considered a passive process of dead and dying cells, research from laboratories worldwide has identified that arteriosclerotic matrix calcification is an actively regulated form of tissue biomineralization. 4 As in the developing skeleton, 36 molecular and histoanatomic heterogeneity exists in vascular calcium deposition. 15 In advanced atherosclerosis, such as that recapitulated by the ApoE-null mouse 47 and LDLR-null mice on fatty diets for 4 months or more, 12 osteochondrogenic regulatory programs drive endochondraltype vascular mineralization, with contributions of dystrophic calcification also observed within cholesterol-laden lipid deposits. 11 With time, advanced lesions can remodel to form woven bone with active hematopoiesis (ie, vascular osteogenesis). 4, 48 Elegant data from Giachelli and colleagues demonstrate that osteochondrogenic transdifferentiation of VSMCs drives atherosclerotic calcification process in ApoEdeficient mice. 47 In the setting of chronic renal insufficiency, the hyperphosphatemic milieu of uremia further enhances osteochondrogenic transdifferentiation, 49 with VSMC apoptosis contributing to medial and intimal calcium load. 50 In T2DM, medial calcification predominates, driven by lowgrade systemic inflammation of obesity and diabetes. 4, 15 These clinically relevant stimuli are recapitulated in male LDLR-deficient mice fed HFD 15, 25, 51 but not in ApoEdeficient mice. 15, 51 When fed the HFD, male LDLR Ϫ/Ϫ mice become increasingly obese, hyperglycemic, hyperinsulinemic, and dyslipidemic with concomitant aortic calcification. 11 During early disease stages, medial artery calcification predominates, as revealed by Alizarin red staining, without significant endochondral contributions. 11 Aortic Msx2-Wnt signaling, reminiscent of membranous ossification, 36 is upregulated early on in the LDLR-deficient model. 11, 15, 16 At later stages, aortic medial calcification is progressively accompanied by atherosclerotic calcification, including mineralization of cholesterol-laden lipid deposits. 11 Thus, in response to clinically relevant stimuli (eg, diet-induced diabetes, obesity, and dyslipidemia), initiation and progression phases of arterial calcification in T2DM can be studied in detail. 15 In both diabetic LDLR-deficient and atherosclerotic ApoE-deficient models, inflammation, oxidative stress, and MMP proteolytic remodeling have emerged as contributors to vascular calcium deposition. 4, 15 The endocrine mechanisms controlling arteriosclerotic mineralization are only beginning to be understood. 4 In this study, we focused on VSMC-autonomous PTH1R signaling and its impact on diabetic vascular disease. Daily PTH(1-34) administration, a potent stimulus for PTH1R activation and bone formation, reduces aortic OPN expression, downregulates aortic osteogenic Msx2-Wnt signaling, and decreases aortic calcification in LDLR Ϫ/Ϫ mice. 16, 25 Because the PTH1R is expressed in VSMCs, as well as in osteoblasts, reductions in vascular mineralization could arise from direct vascular actions of PTH(1-34), as well as indirect actions via the hematopoietic bone marrow-vascular axis. 4, 12, 25 Implementing the VSMCspecific 0.5-kb SM22 promoter 30 to express constitutively active Jansen receptor PTH1R(H223R), 29 we now demonstrate that the PTH1R exerts VSMC-autonomous actions that inhibit proosteogenic and profibroblast Wnt/␤-catenin signaling. Mural oxidative stress was concomitantly reduced by the SM-caPTH1R transgene. Because ROS inactivate the autoinhibitory MMP9 propeptide, oxidative stress enhances matrix turnover. 23 Guzman and colleagues demonstrated the critical role for MMPs in vascular calcification, using a vitamin D toxicity model. 52 Elastinolysis is certainly one contributor 4 ; however, seminal studies by George and colleagues have demonstrated that MMP9 and MMP12 stimulate ␤-catenin signaling by proteolyti-cally liberating the N-cadherin-associated VSMC ␤-catenin pool. 19 Thus, in addition to direct inhibition of ␤-catenin signaling, PTH1R-mediated downregulation of vascular ROS and MMP9 may also help preserve N-cadherin-dependent restraint of ␤-catenin in diabetic arteriosclerosis (Figure 7 ).
The precise intracellular signaling cascade whereby the PTH1R inhibits VSMC ␤-catenin actions has yet to be delineated. Because ␤-catenin protein levels are reduced by PTH1R activity in VSMCs, ubiquitin-dependent ␤-catenin proteolysis is likely involved. 53 However, if so, this mechanism must be cell type-specific because protein kinase A, a key PTH1R mediator that inhibits Wnt/␤-catenin signaling in VSMCs, augments ␤-catenin accumulation in other cell types. 53, 54 Cell type-specific protein-protein interactions between PTH1R and LRP6 (LDLR-related protein 6), 54 the Wnt coreceptor important in paracrine Msx2-Wnt signaling, 16, 33 may also participate. Recently, however, peroxide has been shown to upregulate ␤-catenin levels and signaling via a ROS-sensitive nucleoredoxin-disheveled relay. 55 Of note, protein kinase A phosphorylates NoxA1 and thereby reduces Nox1 activity, 56 a key source of ROS in diabetic VSMCs. 45 Thus, it is tempting to speculate that inhibition of Nox1dependent ROS signaling 55 mediates PTH1R downregulation of aortic ␤-catenin and pro-MMP9. Alternatively, PTH1R activity may upregulate antioxidant defenses in VSMCs. 6 These potential mechanisms remain to be evaluated.
There are limitations to our study. We have emphasized the impact of VSMC PTH1R signaling on diabetic arterial calcification in the absence of significant renal insufficiency. Chronic renal insufficiency is a common consequence of long-standing T2DM and profoundly accelerates vascular calcium accrual. 57 The phosphate retention that characterizes uremia is a powerful stimulus not only for osteochondrogenic signaling but also for VSMC apoptosis. 50 Thus, it remains to be determined whether VSMC-autonomous PTH1R signaling has any impact on vascular calcification with uremia. Anatomically distinct vascular beds may be differentially impacted by VSMC PTH1R activation. 15 Although MMP9, BMP, and Wnt7 family members are prominent in diseased vessels, 8, 11, 16, 23, 32, 58 the relative contributions of individual components to the biology of diabetic arteriosclerosis have yet to be established. Moreover, although increased aortic distensibility was observed ex vivo, improvements in vascular compliance in response to VSMC PTH1R actions have yet to be demonstrated in vivo, and reductions in vascular ROS may potentially improve endothelium-dependent vasodilatation. Because systemic PTH(1-34) administration reduces adventitial Msx2 and Wnt7 expression, 16 as well as regulates cell products released from the skeletal hematopoietic niche, 28 PTH1R signaling beyond medial VSMCs may play even more important roles in the regulation of vascular calcification. Nevertheless, our study newly identifies the important contributions of VSMC-autonomous PTH1R signaling in limiting diabetic arteriosclerosis. This adds to accumulating data indicating that modulation of vascular PTH1R signaling may be useful as pharmacotherapy for treating cardiovascular disease. 16, 25, 27, 28 . VSMC PTH1R and ␤-catenin signaling in diabetic arteriosclerosis: a working model. Low-grade vascular inflammation and ROS that accompany T2DM promote mural elaboration of TNF, BMP2/4, and Msx2-Wnt signaling cascades that direct osteogenic differentiation of arterial mesenchymal progenitors. 15 VSMC-autonomous PTH1R activation downregulates ROS accumulation, MMP9 activation (degrades N-cadherin 19 ), ␤-catenin protein accumulation and signaling, and Runx2 expression. By mechanisms yet to be identified, systemic PTH(1-34) administration additionally reduces adventitial Msx2 and Wnt mRNA accumulation. 16, 25 The impact of PTH/PTH1R signaling on elastinolysis and matrix crosslinking has yet to be evaluated. Not shown is the important role of Sox9 in specifying the common osteo-/chondroprogenitor, or the Smad signals that convey vascular BMP actions. 4, 58 
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